AMGN vs TGTX · P/E 24, rev $10.05B vs P/E 18, rev $240.3M
Amgen Inc (AMGN) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the AMGN and TGTX stock pages for the full models.
Not investment advice.